Home › Companies › Artificial Intelligence (AI), Biopharma, Biotechnology, Health Care, Life Science, Medical › Healx
Healx
Healx is a rare disease biotechnology company that uses generative AI for drug discovery.
Healx is active in the artificial intelligence (ai), biopharma, biotechnology, health care, life science, medical space based in Europe, Middle East, and Africa (EMEA), founded in 2014.
The company sits in the artificial intelligence (ai), biopharma, biotechnology, health care, life science, medical segment, where it competes on its core product or service.
The business is associated with Europe, Middle East, and Africa (EMEA).
It is recorded at the Series_C stage.
Its team size is recorded as c_00101_00250 employees.
Total disclosed funding stands at about $114.9M.
| Sector | Artificial Intelligence (AI), Biopharma, Biotechnology, Health Care, Life Science, Medical |
|---|---|
| Headquarters | Europe, Middle East, and Africa (EMEA) |
| Founded | 2014 |
| Employees | c_00101_00250 |
| Stage | series_c |
| Total funding | $114,909,855 |
Website: healx.ai
Browse related
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account